This course has expired. View available courses.
Endocrinology
GLP1-RAs and their place in the new T2D treatment algorithm
The introduction of new treatments in diabetes, including injectable non-insulin glycemic modulators, creates new opportunities.
The position of GLP1RA agents in current Australian diabetes treatment algorithms requires GPs to re-think traditional models, including the role of these agents in combination with metformin or as an adjunct to other established treatments.
This program is supported by an independent educational grant provided from Eli Lilly.
DURATION
2 hr
PROFESSION
Physician
# OF CREDITS
4
ACCREDITATION
RACGP CPD Program
EXPIRY DATE
2022-12-31
The introduction of new treatments in diabetes, including injectable non-insulin glycemic modulators, creates new opportunities.
The position of GLP1RA agents in current Australian diabetes treatment algorithms requires GPs to re-think traditional models, including the role of these agents in combination with metformin or as an adjunct to other established treatments.
This program is supported by an independent educational grant provided from Eli Lilly.
Faculty
Dr Marwan Obaid (Endocrinologist)
MBBS BSc(Med) FRACP MMed
A/Prof Gary Kilov (GP)
MBBCh
Launceston, TAS
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Individualising injectable therapy for patients with Type 2 diabetes
- Evaluate the efficacy and safety of GLP 1 receptor agonists compared to insulin
- Identify advantages of GLP1-RAs in specific patient groups compared to oral glucose-lowering medicines or insulin
Accreditation
This Active Learning Module has been approved by RACGP CPD Program for 4 CPD points.
Activity no. 219302
Members are able to claim CPD activity points for 4 points through 'Quick log' on their RACGP CPD Dashboard.
#
of credits: 4
Duration: 2 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
2 hr
Duration
Physician
Profession
4
# of credits
Learning Objectives
Upon completion of this continuing education program participants will be better able to:
- Individualising injectable therapy for patients with Type 2 diabetes
- Evaluate the efficacy and safety of GLP 1 receptor agonists compared to insulin
- Identify advantages of GLP1-RAs in specific patient groups compared to oral glucose-lowering medicines or insulin
RACGP CPD Program
ACCREDITATION
Endocrinology
Learning Category
Diabetes
Topic
0
Price
2022-12-31
Expiry Date
AUS
Region/Language
Course Description
The introduction of new treatments in diabetes, including injectable non-insulin glycemic modulators, creates new opportunities.
The position of GLP1RA agents in current Australian diabetes treatment algorithms requires GPs to re-think traditional models, including the role of these agents in combination with metformin or as an adjunct to other established treatments.
This program is supported by an independent educational grant provided from Eli Lilly.
Faculty
Dr Marwan Obaid (Endocrinologist)
MBBS BSc(Med) FRACP MMed
A/Prof Gary Kilov (GP)
MBBCh
Launceston, TAS
Accreditation
This Active Learning Module has been approved by RACGP CPD Program for 4 CPD points.
Activity no. 219302
Members are able to claim CPD activity points for 4 points through ‘Quick log’ on their RACGP CPD Dashboard.
2 hr
Duration
0
Price
4
# of credits
